Markets:

Overview

News

Currencies

International

Treasuries

Travere Therapeutics, Inc. - Common Stock (NQ:TVTX)

61.58 -4.21 (-6.40%)

Streaming Delayed Price Updated: 1:30 PM EDT, Sep 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Travere Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 05, 2023

Via Benzinga

What's Going On With Travere Therapeutics Stock? ↗

December 05, 2023

Travere Therapeutics, Inc. (NASDAQ: TVTX) shares are trading higher Tuesday.

Via Benzinga

NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday ↗

December 05, 2023

U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points on Tuesday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 04, 2023

Via Benzinga

Where Travere Therapeutics Stands With Analysts ↗

November 20, 2023

Via Benzinga

Preview: Travere Therapeutics's Earnings ↗

November 06, 2023

Via Benzinga

Expert Ratings for Travere Therapeutics ↗

September 22, 2023

Via Benzinga

Analyst Ratings for Travere Therapeutics ↗

September 06, 2023

Via Benzinga

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

The Latest Analyst Ratings for Travere Therapeutics ↗

August 18, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 ↗

September 22, 2023

Via Benzinga

Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday ↗

September 22, 2023

Loop Capital increased the price target for Splunk Inc. (NASDAQ: SPLK) from $135 to $157. Loop Capital analyst Yun Kim downgraded the stock from Buy to Hold. Splunk shares fell 0.1% to $144.25 in...

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics' Prospects, Challenges ↗

September 21, 2023

William Blair downgraded Travere Therapeutics Inc (NASDAQ: TVTX)

Via Benzinga

Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit ↗

September 21, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday. The Dow traded down 0.58% to 34,239.48 while the NASDAQ fell 1.20% to 13,307.77. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 21, 2023

Via Benzinga

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 21, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Via Benzinga

Why Shares of Travere Therapeutics Are Slumping Thursday ↗

September 21, 2023

A mixed trial could hurt a kidney drug's chances of full approval.

Via The Motley Fool

Why Former Highflier Travere Therapeutics Just Crashed 41% To A Decade-Low ↗

September 21, 2023

It's now up to the FDA whether the company's key drug remains on the market.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Gold Down Over 1%; FedEx Shares Rise On Earnings Beat ↗

September 21, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 150 points on Thursday. The Dow traded down 0.46% to 34,284.15 while the NASDAQ fell 1.05% to 13,327.80. The S&P 500...

Via Benzinga

Topics Stocks

Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected ↗

September 21, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.56% to 34,248.45 while the NASDAQ fell...

Via Benzinga

Topics Stocks

Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today? ↗

September 21, 2023

Travere Therapeutics Inc (NASDAQ: TVTX) announced

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 21, 2023

Via Benzinga

Broadcom, KB Home And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

September 21, 2023

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Evercore ISI Group Maintains Outperform Rating for Travere Therapeutics: Here's What You Need To Know ↗

September 19, 2023

Via Benzinga

EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug ↗

September 08, 2023

Calliditas, a rare disease company focused on kidney ailments, is optimistic of its lead drug taking off in a big way.

Via Benzinga

3 Small-Cap Stocks That Could Be Big-Time Winners ↗

July 22, 2023

These stocks come with significant risks. But they could generate huge returns over time.

Via The Motley Fool

Biotech Stock Travere Therapeutics Is Trading At A Deep Discount: JPMorgan ↗

July 21, 2023

Travere Therapeutics shares have lost nearly 30% since early May.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 ↗

July 21, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.